Morphologic and immunophenotypic features of therapy-related acute myeloid leukemia/myelodysplasia (t-AML/MDS) with balanced 21q22 translocations

被引：0
|
作者：
Arber, DA
Slovak, ML
Popplewell, L
Bedell, V
Rowley, JD
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
909
引用
收藏
页码：155A / 155A
页数：1
相关论文
共 50 条
  • [1] Morphologic and immunophenotypic features of therapy-related acute myeloid leukemia myelodysplasia (t-AML/MDS) with balanced 21q22 translocations
    Arber, DA
    Slovak, ML
    Popplewell, L
    Bedell, V
    Rowley, JD
    MODERN PATHOLOGY, 2001, 14 (01) : 155A - 155A
  • [2] Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations
    Arber, DA
    Slovak, ML
    Popplewell, L
    Bedell, V
    Ikle, D
    Rowley, JD
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 117 (02) : 306 - 313
  • [3] Therapy related acute myeloid leukemia/myelodysplasia (t-AML/MDS) revisited
    Singh, ZN
    Smith, SM
    Le-Beau, MM
    Larson, RA
    Karrison, T
    Huo, T
    Anastasi, J
    MODERN PATHOLOGY, 2005, 18 : 250A - 250A
  • [4] Therapy related acute myeloid leukemia/myelodysplasia (t-AML/MDS) revisited
    Singh, ZN
    Smith, SM
    Le-Beau, MM
    Larson, RA
    Karrison, T
    Huo, D
    Anastasi, J
    Vardiman, JW
    LABORATORY INVESTIGATION, 2005, 85 : 250A - 250A
  • [5] THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-AML) VERSUS AML WITH MYELODYSPLASIA-RELATED CHANGES AND DE NOVO AML: CLINICOBIOLOGICAL DIFFERENCES AND OUTCOME
    Lalayanni, C.
    Antoniou, A.
    Baliakas, P.
    Iskas, M.
    Georgiadou, E.
    Marvaki, A.
    Syrigou, A.
    Athanasiadou, A.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 503 - 503
  • [6] Therapy-related leukemia with a novel 21q22 rearrangement
    Izumi, T
    Ohtsuki, T
    Ohya, KI
    Ogawa, Y
    Yoshida, M
    Muroi, K
    Imagawa, S
    Hatake, K
    Kuriki, K
    Saito, K
    Miura, Y
    CANCER GENETICS AND CYTOGENETICS, 1996, 90 (01) : 45 - 48
  • [7] CLINICAL AND PROGNOSTIC CHARACTERISTICS OF 484 PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROME (T-MDS) OR ACUTE MYELOID LEUKEMIA (T-AML)
    Kuendgen, A. K.
    Haase, D.
    Giagounidis, A.
    Blum, S.
    Fischer, S.
    Platzbecker, U.
    Schlenk, R.
    Hildebrandt, B.
    Valent, P.
    Stadler, M.
    Stauder, R.
    Krieger, O.
    Goetze, K.
    Hofmann, W. K.
    Ganser, A.
    Mende, C.
    Haas, R.
    Gattermann, N.
    Germing, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 284 - 285
  • [8] FISH TO INVESTIGATE TET2 INVOLVEMENT IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS) AND ACUTE MYELOID LEUKEMIA (T-AML)
    Bernasconi, P.
    Dambruoso, I.
    Boni, M.
    Astori, C.
    Zappasodi, P.
    Cavigliano, P. M.
    Giardini, I.
    Rocca, B.
    Zappatore, R.
    Calvello, C.
    Caresana, M.
    Brusamolino, E.
    Castagnola, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 24 - 24
  • [9] Comparison of prognostic factors and outcomes of patients with secondary acute myeloid leukemia (AML) following myelodysplastic syndromes (MDS), myeloproliferative disorders (MPD), or therapy-related AML (t-AML)
    Mohan, Sanjay
    Elson, Paul
    Rodriguez, Cristina
    Baz, Rachid
    Kalaycio, Matt
    Sobecks, Ronald
    Advani, Anjali
    Maciejewski, Jaroslaw P.
    Copelan, Edward
    Sekeres, Mikkael A.
    BLOOD, 2007, 110 (11) : 140B - 141B
  • [10] Therapy-related myelodysplastic syndrome (t-MDS) following treatment of acute myeloid leukemia (AML)
    Arana-Yi, C.
    Block, A. W.
    Sait, S. N.
    Ford, L. A.
    Barcos, M.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345